Abstract

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a procedure to delivered chemotherapy directly while heating in the peritoneal cavity after a special surgical effort which described as cytoreductive surgery (CRS). The aim of this method is to eliminate surgically and medically all the visible tumor deposits from different tumors. The last decade the interest of this treatment in peritoneal metastasis of different gynecological tumors as ovarian, endometrial or cervical are reported with different trials. This article reviews the current literature and evidence of this procedure.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.